Delivery Order SPE2DB22D2007-SPE2DB25FH9WG
Award Date
3/13/25
Potential Completion Date
4/3/25
Potential Value
$50K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,963.40 delivery order contract is for REVLIMID 5 MG CAPSULE 28S and has a completion date of January 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $74,890.20, is a Firm Fixed Price Delivery Order for the supply of REVLIMID 10 MG CAPSULE 28S, a pharmaceutical product. The contract has an ultimate completion date of January 24, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,722.57 firm-fixed-price delivery order is for the supply of REVLIMID 25 MG CAPSULE 21S, a specialty pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) and is valued at $49,926.80. The contract is a Firm Fixed Price Delivery Order that runs through February 18, 2025. The award is not associated with a set-aside program, indicating open competition. The contract covers the supply of REVLIMID 10 MG CAPSULE 28S, a pharmaceutical product, to support DLA's medical supply needs. Amerisourcebergen holds a...
The U.S. Defense Logistics Agency (DLA) awarded a $49,926.80 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. This contract is for the supply of 10 mg REVLIMID capsules, a pharmaceutical product, to support government healthcare programs. The contract has an ultimate completion date of September 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, is delivering these critical medical commodities without any set-aside designation....
This federal contract award is a delivery order with a ceiling value of $24,963.40 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REVLIMID 5 MG CAPSULE 28S, a pharmaceutical product, with a period of performance through November 2024. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $18,722.57 Firm Fixed Price contract is for the delivery of 4565833098 REVLIMID 25 MG CAPSULE 21S, a specialty oncology medication, with a completion date of October 7, 2024. The award is not associated with any set-aside program. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract is valued at $89,155.06 and covers the delivery of REVLIMID 10 MG CAPSULE 100S, a specialty medication. The award has an ultimate completion date of December 16, 2024. Amerisourcebergen holds a large $999,999,999 IDC with the DLA Troop Support Medical, which serves as a...
This federal contract award SPE2DB22D2007|SPE2DB25FH9QG was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $49,926.80 firm-fixed-price delivery order is for the supply of REVLIMID 10 MG CAPSULE 28S, a specialty medication. The contract has an ultimate completion date of March 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is for the delivery of REVLIMID 5 MG CAPSULE 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $24,963.40 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 13, 2024. The contract has an ultimate completion date of December 5, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...